Details
Description
This poster describes a project that estimated the prevalence of CLE phenotypes among pediatric and adult populations in the FDA Sentinel Distributed Database (SDD), which includes commercial and public insurance data, with primary emphasis on diagnoses coded by dermatologists or rheumatologists and comparison with diagnoses identified without provider-specialty restrictions. It was presented at the 2026 ISPE Annual Meeting.
Additional Information
Contributors
Presenter(s)
Bahareh Rasouli